Investing Ideas
/
Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

4 new

Companies with a Value score of at least 3, ordered by Value score

27 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NEWBRY Newbury Pharmaceuticals	SEK 3.32	-2.9%	-22.6%	SEK 80.5m	SEK 8.00	PS2.5x	E146.2%	n/a
DVYSR Devyser Diagnostics	SEK 130.50	-6.1%	45.6%	SEK 2.2b	SEK 164.98	PS10x	E96.9%	n/a
AZN AstraZeneca	SEK 1,587.00	-1.0%	18.7%	SEK 181.5b	SEK 1,907.18	PE32.4x	E16.5%	2.1%
BIOT Biotage	SEK 108.70	-20.4%	-38.2%	SEK 8.7b	SEK 195.00	PE33.9x	E28.3%	1.5%
AROC AroCell	SEK 0.63	7.7%	52.9%	SEK 145.1m	SEK 0.90	PS2.8x	E25.6%	n/a
SOBI Swedish Orphan Biovitrum	SEK 314.20	-2.0%	18.7%	SEK 107.9b	SEK 368.42	PE27.8x	E17.2%	n/a
MCAP MedCap	SEK 395.00	0.3%	3.5%	SEK 5.9b	SEK 535.00	PE28.5x	S12.9%	n/a
CHOSA Chosa Oncology	SEK 0.53	0%	-59.2%	SEK 34.4m	n/a	PB2x	n/a	n/a
ACE Ascelia Pharma	SEK 3.37	10.9%	-59.2%	SEK 323.9m	SEK 7.68	PB4.1x	E66.9%	n/a
ISAB Inhalation Sciences Sweden	SEK 4.34	0%	24.4%	SEK 65.8m	SEK 16.50	PS3.8x	S59.5%	n/a
NICA New Nanologica	SEK 1.87	-11.0%	-73.7%	SEK 165.2m	SEK 4.00	PS11.4x	S80.0%	n/a
CLBIO Corline Biomedical	SEK 10.45	-6.7%	-20.8%	SEK 255.9m	SEK 20.50	PS14.8x	E105.9%	n/a
LPGO Lipigon Pharmaceuticals	SEK 0.14	-14.7%	-66.3%	SEK 21.0m	SEK 0.90	PS2.3x	E139.5%	n/a
ELIC Elicera Therapeutics	SEK 2.55	-9.3%	41.3%	SEK 89.5m	SEK 4.20	PS12.6x	S119.9%	n/a
ORX Orexo	SEK 16.98	6.0%	18.9%	SEK 585.9m	SEK 20.50	PS1x	E81.0%	n/a
VITR Vitrolife	SEK 212.80	7.2%	12.9%	SEK 28.8b	SEK 269.20	PE56.2x	E18.0%	0.5%
MAGLE Magle Chemoswed Holding	SEK 34.60	4.2%	34.1%	SEK 709.9m	SEK 48.00	PE42.4x	S27.0%	n/a
SENZA SenzaGen	SEK 6.05	-13.6%	-10.5%	SEK 178.5m	SEK 14.50	PS3.1x	E133.9%	n/a
XBRANE Xbrane Biopharma	SEK 0.16	-7.6%	-93.0%	SEK 243.6m	SEK 0.45	PS1.2x	E128.5%	n/a
NXTCL New NextCell Pharma	SEK 3.28	-1.8%	43.2%	SEK 239.7m	SEK 8.00	PS25.4x	S116.8%	n/a
BIOA B New BioArctic	SEK 235.20	8.4%	6.6%	SEK 20.8b	SEK 331.60	PS80.8x	E41.4%	0%
SYNACT SynAct Pharma	SEK 17.64	13.0%	121.6%	SEK 864.5m	SEK 16.00	PB4x	S149.8%	n/a
ONCO Oncopeptides	SEK 1.41	-8.8%	-79.9%	SEK 304.3m	SEK 2.73	PS11.2x	E35.8%	n/a
SECARE Swedencare	SEK 45.06	-5.1%	-25.8%	SEK 7.2b	SEK 58.67	PE72.4x	E40.0%	0.6%

Page 1 of 2